Esomeprazole Magnesium
Product Images NDC 71256-004

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 71256-004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cisen Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Esomeprazole Magnesium Structural Formula (Image 01)

Esomeprazole Magnesium Structural Formula (Image 01)
Chemical structure of esomeprazole magnesium trihydrate, showing the molecular arrangement of atoms and bonds in the compound.*
FDA Label Image

Figure 2: Maintenance Of Healing Rates By Month (study 177) (Image 02)

Figure 2: Maintenance Of Healing Rates By Month (study 177) (Image 02)
A line graph titled 'Maintenance of Healing Rates by Month (Study 177)' showing percent healing maintained over 6 months. The graph compares esomeprazole magnesium delayed-release capsules at 40 mg, 20 mg, and 10 mg doses versus placebo, with the y-axis labeled 'Percent Maintained' and the x-axis labeled 'Month'. Higher doses show greater maintenance of healing over time compared to placebo.*
FDA Label Image

Figure 3: Maintenance Of Healing Rates By Month (study 178) (Image 03)

Figure 3: Maintenance Of Healing Rates By Month (study 178) (Image 03)
A line graph titled "Maintenance of Healing Rates by Month (Study 178)" showing percent maintained on the y-axis (0 to 100) and months on the x-axis (0 to 6). It compares healing rates for Esomeprazole Magnesium delayed-release capsules at 40 mg, 20 mg, and 10 mg doses versus placebo over 6 months. Higher doses maintain near 100% healing rates, with placebo showing a steep decline over time.*
FDA Label Image

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) (Image 04)

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) (Image 04)
A line graph showing the percent of patients symptom-free of heartburn by day over 28 diary days for three groups: Esomeprazole Magnesium Delayed-release Capsules 40 mg, 20 mg, and placebo. The y-axis represents the percent of patients symptom-free, ranging from 0 to 100%, and the x-axis represents diary days from 0 to 28. The graph compares symptom-free rates for the two dosages and placebo across the study period.*
FDA Label Image

Figure 5: Percent Of Patients Symptom-free Of Heartburn By Day (study 226) (Image 05)

Figure 5: Percent Of Patients Symptom-free Of Heartburn By Day (study 226) (Image 05)
A line chart titled 'Percent of Patients Symptom-Free of Heartburn by Day (Study 226)' showing three groups: Esomeprazole Magnesium Delayed-release Capsules 40 mg, Esomeprazole Magnesium Delayed-release Capsules 20 mg, and placebo. The x-axis represents diary days from 0 to 28, and the y-axis represents the percent of patients symptom-free, ranging from 0 to 100%. The chart illustrates higher symptom-free percentages for both Esomeprazole Magnesium doses compared to placebo over the study period.*
FDA Label Image

Esomeprazole Magnesium 20 mg 30 Capsules Bottle Label (Image 06)

Esomeprazole Magnesium 20 mg 30 Capsules Bottle Label (Image 06)
Label for Esomeprazole Magnesium delayed-release capsules, USP 20 mg, supplied in a package of 30 capsules. The label includes storage instructions, dosage form indication, and manufacturer information identifying Cisen Pharmaceutical Co., Ltd. as the labeler, located in Jining, Shandong, China.*
FDA Label Image

Esomeprazole Magnesium 20 mg 90 Capsules Bottle Label (Image 07)

Esomeprazole Magnesium 20 mg 90 Capsules Bottle Label (Image 07)
Label for Esomeprazole Magnesium Delayed-Release Capsules, USP 20 mg by Cisen Pharmaceutical Co., Ltd. The label specifies a quantity of 90 capsules, storage instructions, and states the product is Rx only. It includes the NDC code 71256-003-02 and instructions for the pharmacist to dispense the accompanying medication guide.*
FDA Label Image

Esomeprazole Magnesium Delayed-release Capsules 40 mg 30 Capsules Bottle Label (Image 08)

Esomeprazole Magnesium Delayed-release Capsules 40 mg 30 Capsules Bottle Label (Image 08)
Label for Esomeprazole Magnesium Delayed-Release Capsules, USP 40 mg by Cisen Pharmaceutical Co., Ltd. The label includes storage instructions, dosage form as delayed-release capsules, package size of 30 capsules, and instructions for pharmacists to dispense the accompanying Medication Guide. It specifies Rx Only status and detailed manufacturer information.*
FDA Label Image

Esomeprazole Magnesium Delayed-release Capsules 40 mg 90 Capsules Bottle Label (Image 09)

Esomeprazole Magnesium Delayed-release Capsules 40 mg 90 Capsules Bottle Label (Image 09)
Label for Esomeprazole Magnesium Delayed-Release Capsules, USP 40 mg by Cisen Pharmaceutical Co., Ltd. The label indicates the contents of 90 capsules, prescription-only status, storage instructions, and directions for pharmacists to dispense an accompanying medication guide. The label includes details about the manufacturer and storage temperature recommendations.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.